Company Information

CIN
Status
Date of Incorporation
20 July 1992
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
119,793,440
Authorised Capital
122,000,000

Directors

Rishi Vedprakash Bhatia
Rishi Vedprakash Bhatia
Beneficial Owner
over 2 years ago
Ramnaresh Rajkumar Agrawal
Ramnaresh Rajkumar Agrawal
Director/Designated Partner
over 2 years ago
Shahzad Ali
Shahzad Ali
Director/Designated Partner
about 3 years ago
Alok Bhatia
Alok Bhatia
Director/Designated Partner
over 5 years ago
Manoj Yadneshwar Thakur
Manoj Yadneshwar Thakur
Director/Designated Partner
over 5 years ago

Past Directors

Kashyap Kumar Agrawal
Kashyap Kumar Agrawal
Director
over 8 years ago
Meena Bhatia
Meena Bhatia
Additional Director
almost 15 years ago
Vedprakash Mangaldas Bhatia
Vedprakash Mangaldas Bhatia
Director
almost 22 years ago

Patents

Herbal Composition For Vaginal Treatment

The invention relates to a herbal composition for treatment of vaginal conditions comprising an effective amount of extract of Woodfordia floribunda plant; effective amount of extract of Centella asiatica plant; and an effective amount of at least one pharmaceutically acceptable excipient.

Synthesis Of Remdesivir With Reduced And Controlled Particle Size And Inhalationformulations Thereof

The present invention discloses a process for preparation of Remdesivir with reduced and controlled particle size, desired shape and surface morphology suitable for formulating into pressurized metered dose inhalations (pMDI), dry powder inhalation (DPI) and nebulization compositions. The present invention further r...

Novel Process For Manufacturing Of [2 [2 3(s) 3 [2 (7 Chloro 2 Quinolinyl) Ethyl] Phenyl] 3 Hydroxy Propyl] Phenyl 2 Propanol] On Commercial Scale

The present invention discloses an improved process for the preparation of [2-[2-3(S)-3-[2-(7-Chloro-2-quinolinyl)-ethyl] phenyl]-3-hydroxy propyl] phenyl-2-propanol] (Formula-1), hereinafter referred as a diol intermediate which is a key intermediate of Montelukast or pharmaceutically acceptable salts thereof. The ...

Novel Cost Effective Process For Synthesis Of Molnupiravir

Disclosed herein is the cost effective process for preparation of Molnupiravir of Formula 1. More particularly, the invention discloses a novel process for the synthesis of Molnupiravir with increased efficiency in terms of yield. The present process is suitable for industrialized production.

Cost Effective Process For Synthesis Of Molnupiravir On Commercial Scale

Disclosed herein is the cost effective two-step process for manufacturing of Molnupiravir of Formula 1. More particularly, the invention discloses a novel two-step process for the manufacturing of Molnupiravir with increased efficiency in terms of yield. The present process is suitable for commercial synthesis of Mo...

Registered Trademarks

Ultra Rem Ultratech India

[Class : 5] Medicinal And Pharmaceutical Preparations Included Under Class 5

Ultra Covi Ultratech India

[Class : 5] Medicinal And Pharmaceutical Preparations Included Under Class 5

Ultrarem Ultratech India

[Class : 5] Medicinal And Pharmaceutical Preparations Included Under Class 5
View +45 more Brands for Ultratech India Limited.

Charges

0
30 January 2015
Idbi Bank Limited
9 Crore
12 July 2018
Karnataka Bank Ltd.
14 Crore
30 January 2015
Idbi Bank Limited
17 Crore
08 October 2011
Oriental Bank Of Commerce
6 Crore
21 July 2012
Oriental Bank Of Commerce
6 Crore
01 November 2022
State Bank Of India
0
30 January 2015
Idbi Bank Limited
0
30 January 2015
Idbi Bank Limited
0
21 July 2012
Oriental Bank Of Commerce
0
12 July 2018
Karnataka Bank Ltd.
0
08 October 2011
Oriental Bank Of Commerce
0
01 November 2022
State Bank Of India
0
30 January 2015
Idbi Bank Limited
0
30 January 2015
Idbi Bank Limited
0
21 July 2012
Oriental Bank Of Commerce
0
12 July 2018
Karnataka Bank Ltd.
0
08 October 2011
Oriental Bank Of Commerce
0
01 November 2022
State Bank Of India
0
30 January 2015
Idbi Bank Limited
0
30 January 2015
Idbi Bank Limited
0
21 July 2012
Oriental Bank Of Commerce
0
12 July 2018
Karnataka Bank Ltd.
0
08 October 2011
Oriental Bank Of Commerce
0

Documents

Form MGT-7-09012021_signed
Form MGT-7-09012021_signed
Copy of MGT-8-31122020
List of share holders, debenture holders;-31122020
Form PAS-6-29112020_signed
Form MSME FORM I-29112020_signed
Optional Attachment-(1)-29112020
Form MSME FORM I-11112020_signed
Form DPT-3-09112020_signed
Form AOC-4(XBRL)-04112020_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-29102020
Form BEN - 2-26102020_signed
Declaration under section 90-26102020
Optional Attachment-(1)-26102020
Optional Attachment-(2)-26102020
Form ADT-1-15102020_signed
Copy of written consent given by auditor-15102020
Copy of resolution passed by the company-15102020
Copy of the intimation sent by company-15102020
Form DPT-3-02102020-signed
Form PAS-3-21092020_signed
List of allottees. Attach separate list for each allotment (refer instruction kit for format).If not attached, then it shall be submitted separately in a CD.-21092020
Copy of Board or Shareholders? resolution-21092020
Form DIR-12-19092020_signed
Optional Attachment-(2)-18092020
Optional Attachment-(1)-18092020
Declaration of the appointee director, Managing director, in Form No. DIR-2;-18092020
Form PAS-6-14092020_signed
Optional Attachment-(1)-12092020
Form SH-7-17082020-signed